2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Primary Immunodeficiency Diseases: new trials by email Literature Review of Primary Immunodeficiency Diseases trials Research Report on Primary Immunodeficiency Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| C1-inhibitor in Allergic ASThma Patients C1-inhibitor, Saline, Antibiotics - Asthma | Phase 4 | Terminated | T. van der Poll | 37 | 2016-11-16 | 2020-06-24 |
| Antibody Production in Immune Disorders Pneumovax, Rabavert, Prevnar - Primary Immune Deficiency | Phase 4 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 21 | 2002-06-13 | 2021-10-15 |
Angioedemas, Hereditary (1) · Asthma (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Angioedema (1) · Bronchial Diseases (1) · Cardiovascular Diseases (1) · Hereditary Complement Deficiency Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Respiratory Hypersensitivity (1) · Respiratory Tract Diseases (1)
Anti-Bacterial Agents (1) · Ciprofloxacin (1) · Complement C1 Inhibitor Protein (1) · Heptavalent Pneumococcal Conjugate Vaccine (1) · Metronidazole (1) · Pneumococcal Vaccines (1) · SERPING1 protein, human (1) · Sodium Chloride (1) · Vancomycin (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · T. van der Poll (1)
Netherlands (1) · United States (1)
Gulbu Uzel, M.D. (1)